{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,21]],"date-time":"2023-10-21T22:45:44Z","timestamp":1697928344162},"reference-count":18,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2007,4,28]],"date-time":"2007-04-28T00:00:00Z","timestamp":1177718400000},"content-version":"vor","delay-in-days":8579,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[1983,11]]},"abstract":"<jats:p>Twenty\u2010six pollen\u2010allergic subjects participated in a double\u2010blind, placebo\u2010controlled trial of the protective effect of the calcium antagonist, verapamil, on allergen\u2010provoked nasal symptoms. Intranasal verapamil, 1 mg, had a weak protective effect in that \u201ctickling score\u201d was 22% lower (<jats:italic>P<\/jats:italic> &lt; 0.01) and the number of sneezes 29% lower (nonsignificant) after verapamil as compared with placebo pretreatment. There were no differences with regard to nasal blockage or discharge. It is concluded tha the verapamil spray used, cannot be recommended for clinical trials, but that further investigations of other formulations of calcium antagonists are justified in order to analyse the potential role of this type of drugs in the treatment of allergic rhinitis.<\/jats:p>","DOI":"10.1111\/j.1398-9995.1983.tb04141.x","type":"journal-article","created":{"date-parts":[[2007,5,13]],"date-time":"2007-05-13T23:33:43Z","timestamp":1179099223000},"page":"565-570","source":"Crossref","is-referenced-by-count":4,"title":["Intranasal Verapamil in Allergen\u2010Induced Rhinitis"],"prefix":"10.1111","volume":"38","author":[{"given":"GLAUS","family":"SECHER","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SUSANNE","family":"BROFELDT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NIELS","family":"MYGIND","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,4,28]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"439","article-title":"Standardization of diagnostic work in allergy","volume":"27","author":"Aas K.","year":"1972","journal-title":"Acta Allergol."},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(80)90134-7"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","unstructured":"Broms P. Johnson B.&Lamm C. J.:A universal way to evaluate the curve in rhinomanometry. Acta Otolaryngol. (Stockh.) Suppl. 360 22\u201323 1979.","DOI":"10.3109\/00016487809123460"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6278.1792"},{"key":"e_1_2_1_6_2","first-page":"156","article-title":"Inhibition of exercise\u2010induced asthma by a calcium antagonist, nifedipine","volume":"123","author":"Cerrina J.","year":"1981","journal-title":"Am. Rev. Respir. Dis."},{"key":"e_1_2_1_7_2","unstructured":"McIntyre E. Fitzgibbon B. Otto H. Minson R. Alpers J.&Ruffin R.:Inhaled verapamil in histamine induced bronchoconstriction. (In preparation)."},{"issue":"128","key":"e_1_2_1_8_2","first-page":"123","article-title":"Role of calcium and calcium antagonists in airway function","volume":"64","author":"Middleton E.","journal-title":"Eur. J. Respir. Dis."},{"key":"e_1_2_1_9_2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1378\/chest.80.6.849","article-title":"New approaches to regulation of fluid secretion in airways","volume":"80","author":"Nadel J. A.","journal-title":"Chest"},{"issue":"128","key":"e_1_2_1_10_2","first-page":"394","article-title":"In vivo and in vitro inhibition of histamine release of calcium antagonists","volume":"64","author":"Norn S.","journal-title":"Eur. J. Respir. Dis."},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.282.6268.932"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1981.tb01615.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1981.tb01617.x"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0091-6749(82)90044-6"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-197815030-00001"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/277263a0"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2222.1982.tb02558.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.1983.tb00849.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.283.6287.348"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.1983.tb04141.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.1983.tb04141.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T13:54:45Z","timestamp":1697723685000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.1983.tb04141.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,11]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[1983,11]]}},"alternative-id":["10.1111\/j.1398-9995.1983.tb04141.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.1983.tb04141.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,11]]}}}